Processa Pharmaceuticals, Inc. Distributed Earnings
Processa Pharmaceuticals, Inc. (PCSA) reported Distributed Earnings of -$10.71 thousand for the 3-month period ending 2017-06-30, per its 10-Q filed 2017-10-04.
Discontinued › Notes › Earnings Per Share
us-gaap:DistributedEarnings · last filed 2017-11-20
- Processa Pharmaceuticals, Inc. distributed earnings for the quarter ending 2017-06-30 was -$10.71K.
- Processa Pharmaceuticals, Inc. distributed earnings for the quarter ending 2017-03-31 was -$10.59K.
- Processa Pharmaceuticals, Inc. distributed earnings for the quarter ending 2016-12-31 was -$10.82K.
- Processa Pharmaceuticals, Inc. distributed earnings for the quarter ending 2016-09-30 was -$10.82K.
- Processa Pharmaceuticals, Inc. distributed earnings for fiscal 2016 was -$43.06K.
- Processa Pharmaceuticals, Inc. distributed earnings for fiscal 2015 was -$42.94K, a 102.86% decline from fiscal 2014.
- Processa Pharmaceuticals, Inc. distributed earnings for fiscal 2014 was $1.50M, a 6955.16% increase from fiscal 2013.
- Processa Pharmaceuticals, Inc. distributed earnings for fiscal 2013 was $21.30K.
| Period end | Distributed Earnings 3 month | Distributed Earnings 3 month as first filed | Distributed Earnings 6 month | Distributed Earnings 6 month as first filed | Distributed Earnings 9 month | Distributed Earnings 9 month as first filed | Distributed Earnings 12 month | Distributed Earnings 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2017-06-30 | -$10.71K 10-Q · filed 2017-10-04 | -$21.29K 10-Q · filed 2017-10-04 | -$32.12K derived: sum of 3 quarters · filed 2017-10-04 | -$42.94K derived: sum of 4 quarters · filed 2017-11-20 | ||||
| 2017-03-31 | -$10.59K 10-Q · filed 2017-10-04 | -$21.41K derived: sum of 2 quarters · filed 2017-10-04 | -$32.24K derived: sum of 3 quarters · filed 2017-11-20 | -$42.94K derived: sum of 4 quarters · filed 2017-11-20 | ||||
| 2016-12-31 | -$10.82K derived: 10-K 12 month − 10-Q 9 month · filed 2017-09-25 | -$21.65K derived: sum of 2 quarters · filed 2017-11-20 | -$32.35K derived: sum of 3 quarters · filed 2017-11-20 | -$43.06K 10-K · filed 2017-09-25 | ||||
| 2016-09-30 | -$10.82K 10-Q · filed 2017-11-20 | -$21.53K derived: sum of 2 quarters · filed 2017-11-20 | -$32.23K 10-Q · filed 2017-11-20 | -$43.06K derived: sum of 4 quarters · filed 2017-11-20 | ||||
| 2016-06-30 | -$10.71K 10-Q · filed 2017-10-04 | -$21.41K 10-Q · filed 2017-10-04 | -$32.23K derived: sum of 3 quarters · filed 2017-10-04 | -$43.06K derived: sum of 4 quarters · filed 2017-10-04 | ||||
| 2016-03-31 | -$10.71K 10-Q · filed 2017-10-04 | -$21.53K derived: sum of 2 quarters · filed 2017-10-04 | -$32.35K derived: sum of 3 quarters · filed 2017-10-04 | -$43.06K derived: sum of 4 quarters · filed 2017-10-04 | ||||
| 2015-12-31 | -$10.82K derived: 10-K 12 month − 10-Q 9 month · filed 2017-09-25 | -$21.65K derived: sum of 2 quarters · filed 2017-09-25 | -$32.35K derived: sum of 3 quarters · filed 2017-09-25 | -$42.94K 10-K · filed 2017-09-25 | $42.94K 10-K · filed 2017-06-19 | |||
| 2015-09-30 | -$10.82K 10-Q · filed 2017-09-08 | $10.82K 10-Q · filed 2015-12-01 | -$21.53K derived: sum of 2 quarters · filed 2017-09-08 | -$32.12K 10-Q · filed 2017-09-08 | $32.12K 10-Q · filed 2015-12-01 | $1.33M derived: sum of 4 quarters · filed 2017-09-08 | ||
| 2015-06-30 | -$10.71K 10-Q · filed 2017-08-30 | $10.71K 10-Q · filed 2015-08-19 | -$21.30K 10-Q · filed 2017-08-30 | $21.30K 10-Q · filed 2015-08-19 | $1.34M derived: sum of 3 quarters · filed 2017-08-30 | $1.42M derived: sum of 4 quarters · filed 2017-08-30 | ||
| 2015-03-31 | -$10.59K 10-Q · filed 2017-08-07 | $10.59K 10-Q · filed 2015-05-15 | $1.35M derived: sum of 2 quarters · filed 2017-08-07 | $1.43M derived: sum of 3 quarters · filed 2017-08-07 | $1.49M derived: sum of 4 quarters · filed 2017-08-07 | |||
| 2014-12-31 | $1.36M derived: 10-K 12 month − 10-Q 9 month · filed 2017-06-19 | $1.44M derived: sum of 2 quarters · filed 2017-06-19 | $1.50M derived: sum of 3 quarters · filed 2017-06-19 | $1.50M 10-K · filed 2017-06-19 | ||||
| 2014-09-30 | $79.89K 10-Q · filed 2015-12-01 | $141.02K derived: sum of 2 quarters · filed 2015-12-01 | $139.04K 10-Q · filed 2015-12-01 | |||||
| 2014-06-30 | $61.13K 10-Q · filed 2015-08-19 | $59.15K 10-Q · filed 2015-08-19 | ||||||
| 2014-03-31 | $38.55K 10-Q · filed 2015-05-15 | |||||||
| 2013-12-31 | $21.30K 10-K · filed 2015-04-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |